Moreover, Delsing Malmberg et al. reported that MRD analysis using targeted deep sequencing 3 months after alloHSCT was a strong independent predictor of both relapse risk and OS in adult NPM1-mutated AML patients [65]. Here, NPM1 is linked to acute myeloid leukemia.